In a recent Public Health Advisory, FDA summarized two new studies that practitioners should consider when making decisions about prescribing SSRIs and other antidepressant medications for pregnant women and those planning a pregnancy.
IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted a Marketing Authorization Application (MAA) in eCTD format (electronic common technical document) to the European Medicines Agency (EMEA) for Mepact (mifamurtide for injection), requesting approval for its use in the treatment of patients with newly diagnosed resectable high-grade osteosarcoma following surgical resection in combination with post-operative multi-agent chemotherapy. This announcement follows the October 25, 2006 submission of a New Drug Application (NDA) for Junovan (mifamurtide for injection) to the Food and Drug Administration (FDA) in the United States.
Hodgkin?s lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don?t have the screening and the intervention is cost-effective, according to a study presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology?s 48th Annual Meeting in Philadelphia.
The Academy for Eating Disorders (AED) has drafted the Worldwide Charter for Action on Eating Disorders, an international bill of rights for people with eating disorders and their families, that seeks an end to discrimination against people with eating disorders by insurance and treatment providers.
With the help of tiny, transparent zebrafish embryos, researchers are hoping to prove that a microscopic nanoparticle can be part of a “new class of radioprotective agents” that help protect normal tissue from radiation damage just as well as standard drugs. They’ve shown that the nanoparticle, DF-1 — a soccer ball-shaped, hollow, carbon-based structure known as a fullerene — is as good as two antioxidant drugs and FDA-approved Amifostine in fending off radiation damage from normal tissue.
Doctors in the UK are to treat heart attack patients with stem cells taken from their own bone marrow in a pioneering attempt to prevent death and suffering.
Which works best in fighting the risk factors for diabetes ?exercise or diet? Exercise and diet work equally well in reducing the risk factors for diabetes, a new study finds.
Difficulties in the heart’s ability to fill with blood are common causes of heart failure — and appear to be as significant in placing a heart patient at risk of death as are deficiencies in the heart’s ability to pump blood, new research from Mayo Clinic shows.
The Mayo Clinic Nicotine Research Program is conducting a research study to help smokers who would like to quit. The study will test whether the drug Chantix (varenicline) helps smokers who have Chronic Obstructive Pulmonary Disease (COPD) stop smoking.
A special research program at St. Joseph’s Hospital and Medical Center is providing a safe and vital research component to scientists in hopes of finding new treatments and cures for a variety of disorders.